Basic Information
ID: ALA3829219
Type: Binding
Description: Inhibition of human recombinant farnesyltransferase using farnesylpyrophosphate and dansyl-GCVLS as substrate at 100 uM measured for 15 mins by fluorescence assay
Format: BAO_0000223
Organism: Homo sapiens
Target: Protein farnesyltransferase(ALA2094108)
Document: ALA3826975
Inhibition of human recombinant farnesyltransferase using farnesylpyrophosphate and dansyl-GCVLS as substrate at 100 uM measured for 15 mins by fluorescence assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3829219
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 433.60 | 2.96 | 2.96 |
| 326.48 | 5.56 | 5.56 |
| 409.44 | 4.04 | 4.04 |
| 423.47 | 4.35 | 4.35 |
| 423.47 | 4.35 | 4.35 |
| 423.47 | 4.35 | 4.35 |
| 423.47 | 4.35 | 4.35 |
| 439.46 | 4.05 | 4.05 |
| 409.44 | 4.18 | 4.18 |
| 365.43 | 4.48 | 4.48 |
| 383.83 | 4.67 | 4.67 |
| 355.78 | 4.20 | 4.20 |
| 428.28 | 4.78 | 4.78 |
| 374.40 | 3.89 | 3.89 |
| 379.41 | 4.03 | 4.03 |
| 425.48 | 5.69 | 5.69 |
| 454.55 | 6.24 | 6.24 |
| 468.58 | 6.55 | 6.55 |
| 468.58 | 6.55 | 6.55 |
| 484.58 | 6.25 | 6.25 |